Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Creative Commons License

AYGEN B., DEMİRTÜRK N., YILDIZ O., ÇELEN M. K., ÇELİK İ., BARUT H. Ş., ...Daha Fazla

AASLD - TASL CONNECT REGIONAL MEETING, 15 - 16 Mart 2019, cilt.30, ss.10-15, (Tam Metin Bildiri)